Welcome to our dedicated page for High Tide news (Ticker: HITI), a resource for investors and traders seeking the latest updates and insights on High Tide stock.
High Tide Inc. reports developments tied to its cannabis retail, e-commerce and cannabinoid products businesses. The company operates Canna Cabana stores across several Canadian provinces, uses a discount club retail model, and owns online platforms for consumption accessories and hemp-derived CBD products. News commonly covers store openings, financial results, customer-loyalty activity, and the operating performance of its bricks-and-mortar and e-commerce segments.
High Tide updates also address subsidiaries and international activities, including NuLeaf Naturals in U.S. hemp-derived CBD products and Remexian in Germany. Recurring corporate items include financing arrangements, insider ownership, conference participation, governance matters, and company statements related to the trading of its common shares on Nasdaq, TSXV and other markets.
High Tide (Nasdaq: HITI) opened its 220th Canna Cabana retail store at 1355 London Road in Sarnia, Ontario, beginning sales on March 9, 2026. This is the company’s first Sarnia location and increases its Ontario footprint to 96 stores.
The company said Canna Cabana now operates 220 locations nationwide and holds a growing 12% Canadian market share. High Tide will release Q1 2026 results after markets close on March 17, 2026, with a management webcast at 11:30 AM ET on March 18, 2026.
High Tide (Nasdaq: HITI) and its U.S. hemp-derived CBD subsidiary NuLeaf Naturals joined the U.S. National Compassionate Care Council as founding members on March 4, 2026.
The companies said this role aims to help modernize medical cannabis policy, improve patient access to cannabinoid therapies, and contribute industry expertise amid federal rescheduling and Medicare reimbursement discussions.
Other founding members include Feals, Medterra, Tilray, Realm of Caring, Lazarus Naturals, Constance CBD, and Equilibria.
High Tide (Nasdaq: HITI) announced board renewal effective March 2, 2026, naming Kathleen Skerrett and Menashe Kestenbaum as directors and adding David Wallach and Filip Ernest to the advisory board.
The company granted 123,558 RSUs and 25,000 options at a $3.43 strike for three years to directors, advisors and consultants, and highlighted retail scale (219 Canadian locations, ~12% domestic share) and expanded tech/AI and real estate expertise.
High Tide (Nasdaq: HITI) opened a new Canna Cabana store at 3148 Kingston Road in Scarborough, Ontario on February 9, 2026, bringing the chain to 219 locations in Canada and 95 in Ontario. The site is on a high‑traffic corridor with limited nearby cannabis competition.
The company also granted 145,500 stock options at $3.22 exercisable until February 6, 2029, and 1,300,530 RSUs with staged vesting through February 6, 2029; 795,106 RSUs were granted to directors as a related‑party transaction exempt under MI 61‑101.
High Tide (Nasdaq: HITI) reported record Q4 revenue of $164.0M and a fiscal 2025 revenue run-rate > $650M, with record Adjusted EBITDA of $12.4M in Q4 and annual free cash flow of $12.0M. The company added 34 Canna Cabana stores in calendar 2025 to reach 218 locations and closed a 51% acquisition of Remexian Pharma to enter the German medical cannabis market.
Q4 same-store sales rose 5.5% YoY (4.1% for fiscal 2025), gross profit was $42.5M (26% margin), and cash and cash equivalents were $47.9M as at Oct 31, 2025.
Summary not available.
High Tide (Nasdaq: HITI) will release its fourth fiscal quarter and full fiscal year 2025 financial and operational results for the period ended October 31, 2025 after market close on January 29, 2026. Results will be available on SEDAR+, EDGAR and the company's investor website. A webcast with CEO Raj Grover and CFO Mayank Mahajan will be held at 11:30 AM ET on January 30, 2026 with a replay available three hours after the live event.
The release outlines High Tide's retail and medical distribution operations and provides investor contact details and cautionary forward-looking statements.
High Tide (Nasdaq: HITI) recapped 2025 milestones including domestic expansion and international entry into Germany via a majority stake in Remexian Pharma.
Key metrics: an annualized revenue run-rate of $600M (pre-Remexian), an annualized Adjusted EBITDA run-rate of over $42M, same-store sales +7.4% in Q3 2025, retail sales per square foot of $1,735 in Q3 2025, 218 Canna Cabana stores, ~2.4M Cabana Club members (including 139,000 ELITE), +27 new stores in 2025, and a 12% market share across five Canadian provinces.
High Tide (Nasdaq: HITI) will participate in the ICR Conference in Orlando, Florida, hosting two days of meetings with institutional investors and a public fireside chat. The fireside chat features Raj Grover, Founder and CEO, moderated by Bill Kirk of ROTH Capital Partners, scheduled for 8:00 a.m. EST on Tuesday, January 13, 2026. The company said the conference is an opportunity to showcase its retail-focused platform and recent momentum following a record 2025.
High Tide describes its retail brand Canna Cabana as a major asset (218 Canadian and 1 international location) and highlights medical distribution via Remexian in Germany and other corporate recognitions through 2025.
High Tide (Nasdaq: HITI) welcomed a White House Executive Order advancing cannabis rescheduling and an announced CMS pilot to allow certain Medicare beneficiaries to receive CBD treatments at no cost, dated Dec 18, 2025. The company said its U.S. CBD brands, NuLeaf Naturals and FAB CBD, will evaluate Medicare-aligned product categories and that it is assessing U.S. licensing pathways to expand its Canna Cabana retail brand while maintaining NASDAQ and TSXV compliance.
The company reengaged an IR agency effective Dec 19, 2025 at a fee of USD $140,000 per month on a fee-for-service basis.